BFS
DNA icon

Bickling Financial Services’s Ginkgo Bioworks DNA Stock Holding History

Bickling Financial Services’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$20.4K Sell
302
-5
-2% -$460 0.01% 119
2022
Q3 		$39K Hold
307
– – 0.03% 115
2022
Q2 		$29K Buy
+307
New +$37.4K 0.02% 119

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Bickling Financial Services's DNA Position: Q4 2022 in Review

Bickling Financial Services reduced its Ginkgo Bioworks (DNA) stake by 1.6% in Q4 2022, selling an estimated $460 and leaving 302 shares worth $20.4K. The position accounts for 0.01% of the portfolio, ranked #119.

Bickling Financial Services first reported a position in DNA in Q2 2022 and has held it in 3 quarters since. The position peaked at $39K in Q3 2022. 320 funds tracked by Wall St. Rank hold DNA as of Q4 2022.

  • Bickling Financial Services held 302 shares of Ginkgo Bioworks worth $20.4K as of Q4 2022.
  • Bickling Financial Services sold 5 Ginkgo Bioworks shares in Q4 2022, an estimated $460.
  • Ginkgo Bioworks made up 0.01% of Bickling Financial Services's portfolio in Q4 2022, its #119 holding.
  • Bickling Financial Services first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 3 quarters since.
  • Bickling Financial Services's Ginkgo Bioworks position peaked at $39K in Q3 2022.
  • 320 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2022.

Based on Bickling Financial Services's 13F filing for Q4 2022, filed 31 Jan 2023.